Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil

Completed · Phase 4 · Has a placebo group

Conditions studied: Bipolar Disorder

In brief

This is an 8-week, randomized, placebo-controlled trial of modafinil in stable bipolar disorder patients. Results will provide information on a promising treatment for simultaneously treating both sleep and cognitive problems in stable bipolar patients. These disabling symptoms persist despite stable mood and are strongly associated with functional disability, making them important treatment targets that have not yet been adequately addressed.

Key facts

Study ID
NCT01965925
Run by
Icahn School of Medicine at Mount Sinai
People needed
18
Starts
2014-01-01
Expected to finish
2017-11-09
Last updated by the study team
2018-03-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.